Calorie Restriction Attenuates Cardiac Remodeling and Diastolic Dysfunction in a Rat Model of Metabolic Syndrome

• Published in: Hypertension (Dallas, Tex. 1979) Tex. 1979), 2013-11, Vol.62 (5), p.957-965
• Main Authors: Takatsu, Miwa, Nakashima, Chieko, Takahashi, Keiji, Murase, Tamayo, Hattori, Takuya, Ito, Hiromi, Murohara, Toyoaki, Nagata, Kohzo
• Format: Article
• Language: English
• Subjects: Animals; Arterial hypertension. Arterial hypotension; Biological and medical sciences; Blood and lymphatic vessels; Blood Pressure; Body Weight; Caloric Restriction; Cardiology. Vascular system; Disease Models, Animal; Heart; Heart - physiopathology; Heart failure, cardiogenic pulmonary edema, cardiac enlargement; Hypertension - complications; Hypertension - metabolism; Hypertension - physiopathology; Male; Medical sciences; Metabolic diseases; Metabolic Syndrome - complications; Metabolic Syndrome - metabolism; Metabolic Syndrome - physiopathology; Miscellaneous; Obesity - complications; Obesity - metabolism; Obesity - physiopathology; Other metabolic disorders; Oxidative Stress - physiology; Rats; Rats, Inbred Dahl; Rats, Zucker; Ventricular Remodeling - physiology
• ISSN: 0194-911X; 1524-4563
• DOI: 10.1161/HYPERTENSIONAHA.113.02093

Calorie restriction (CR) can modulate the features of obesity-related metabolic and cardiovascular diseases. We have recently characterized DahlS.Z-Lepr/Lepr (DS/obese) rats, derived from a cross between Dahl salt-sensitive and Zucker rats, as a new animal model of metabolic syndrome. DS/obese rats develop hypertension and manifest left ventricular remodeling and diastolic dysfunction, as well as increased cardiac oxidative stress and inflammation. We have now investigated the effects of CR on cardiac pathophysiology in DS/obese rats. DS/obese rats were fed either normal laboratory chow ad libitum or a calorie-restricted diet (65% of the average food intake for ad libitum) from 9 to 13 weeks. Age-matched homozygous lean (DahlS.Z-Lepr/Lepr or DS/lean) littermates served as controls. CR reduced body weight in both DS/obese and DS/lean rats, as well as attenuated the development of hypertension in DS/obese rats without affecting blood pressure in DS/lean rats. CR also reduced body fat content, ameliorated left ventricular hypertrophy, fibrosis, and diastolic dysfunction, and attenuated cardiac oxidative stress and inflammation in DS/obese rats. In addition, it increased serum adiponectin concentration, as well as downregulated the expression of angiotensin-converting enzyme and angiotensin II type 1A receptor genes in the heart of DS/obese rats. Our results thus show that CR attenuated obesity and hypertension, as well as left ventricular remodeling and diastolic dysfunction in DS/obese rats, with these latter effects being associated with reduced cardiac oxidative stress and inflammation.